Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-06

Clinical Trial Update: Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 trial comparing alfentanil and remifentanil for patient-controlled sedation during ERCP. The study involved pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfentanil (alfentanil)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Biliary Tract Diseases, Pancreatic Diseases | Phase 4 | Status: COMPLETED